saascode
healthcare & clinical·run 014 · Apr 2026

Pauriel

An embedded prior-authorization workspace for smaller clinics that extracts chart evidence into reviewable questionnaire candidates, submits only under authorized clinician policy, and tracks payer acknowledgements and decisions.

Genesis score0.00/10
Make Pauriel real.0/500
500 more votes and Pauriel is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The case

Smaller clinics can lose time leaving the chart to assemble prior-authorization requests across payer portals and forms. Pauriel proposes an embedded evidence workflow, not autonomous clinical or coverage decision-making. Chart extraction, questionnaire candidate, clinician confirmation, submission command, payer acknowledgement, request for information, determination, appeal, treatment decision, and payment remain separate.

Who pays — and why

A practice administrator, revenue-cycle leader, or clinical operations owner at a smaller non-enterprise clinic. The source explicitly lacks a validated buyer and budget.

Market signal$112,500/yr was cited for one adjacent interoperability plan and $75,000+/yr for an enterprise prior-authorization vendor; both require direct commercial validation.Observed market reference, not fixed product pricing
What it unlocks
An in-chart case record that preserves patient, order, payer, plan, policy version, and source evidence
Questionnaire and attachment candidates with field provenance, missing evidence, and clinician correction
Explicit authorization before submission plus payer acknowledgement and status readback
Outcome tracking that separates authorization, coverage, clinical decision, service delivery, claim adjudication, and payment
How Genesis scored it
0.00across seven criteria
tension 6temporal 8blindspot 5buyer 4leverage 7convergence 5why-not 7
8
Temporal window

The cited January 2027 timeline creates pressure, subject to current official applicability and scope.

7
Asymmetric leverage

Evidence extraction and workflow are software-scalable, but each payer and record-system connection adds work.

4
Buyer persona

The source explicitly lacks a validated buyer despite plausible practice operations roles.

Why it scored well

Five cross-references and sixteen inbound links support recurrence. A named federal interoperability timeline and confirmed interfaces create timing and viability, while the smaller-clinic gap is plausible.

What's holding it back

The stored score is zero and the source explicitly reports no buyer. Interface availability is payer- and record-system-specific, current rule status needs official verification, healthcare integration and privacy are costly, and no structural incumbent disadvantage is proven.

Signals detected3 sources crossed
SignalSMART on FHIR client and CMS developer portal review

Signal1upHealth and Rhyme review

SignalFederal Register review

Direction briefpauriel.md
pauriel.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.